1. Home
  2. TWLO vs RVMD Comparison

TWLO vs RVMD Comparison

Compare TWLO & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twilio Inc.

TWLO

Twilio Inc.

HOLD

Current Price

$140.35

Market Cap

19.1B

Sector

Technology

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$140.79

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWLO
RVMD
Founded
2008
2014
Country
United States
United States
Employees
5587
883
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1B
19.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TWLO
RVMD
Price
$140.35
$140.79
Analyst Decision
Buy
Strong Buy
Analyst Count
24
19
Target Price
$151.54
$140.84
AVG Volume (30 Days)
2.2M
3.8M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.44
N/A
Revenue Next Year
$8.21
$533.02
P/E Ratio
$526.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$91.84
$34.00
52 Week High
$154.64
$155.70

Technical Indicators

Market Signals
Indicator
TWLO
RVMD
Relative Strength Index (RSI) 57.17 62.82
Support Level $117.98 $93.39
Resistance Level $145.90 $155.70
Average True Range (ATR) 6.30 7.53
MACD 0.39 -0.07
Stochastic Oscillator 65.93 75.43

Price Performance

Historical Comparison
TWLO
RVMD

About TWLO Twilio Inc.

Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: